Oak Woods Acquisition Corp (OAKUU) Return on Investment ROI from the second quarter of 2025 to second quarter of 2024 and for the year 2025, average high and low, overall ranking from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket
 


Oak Woods Acquisition Corp  (NASDAQ: OAKUU)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Oak Woods Acquisition's ROI from its second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Oak Woods Acquisition's ROI in the second quarter of 2025?
Oak Woods Acquisition Corp achieved a return on average invested assets (ROI) of 106.75 % in its second quarter of 2025, this is above OAKUU's average return on investment of 28.85%.
Oak Woods Acquisition Corp invested over the 12 months ending in its second quarter of 2025 $44 million

Despite the deterioration in its net income, company has improved ROI compared to the first quarter of 2025.

Within the Healthcare sector 221 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2025 from 2425 to 2675.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
Y / Y Investment Change TTM -26.33 % -16.14 % -5.8 % 1.22 % 35.89 %
Y / Y Net Income Change TTM -20.41 % -21.55 % -21.04 % -20.13 % 10602.29 %
Investment (TTM) in Millions 36 37 45 59 60
Return On Investment (TTM) 106.75 % 93.88 % 84.43 % 79.63 % 98.81 %
OAKUU's Overall Ranking # 2675 # 2425 # 2389 # 0 # 2059
Seq. Investment Change TTM -11.88 % -10.43 % -6.38 % -0.3 % 0.3 %
Seq. Net Income Change TTM 0.19 % -0.4 % -0.73 % -19.66 % -1.24 %
Net Income (TTM) in Millions 47 47 48 48 60




Return On Investment OAKUU's Ranking
Within: No.
Industry # 31
Sector # 222
Overall # 2675

Return On Investment Statistics
High Average Low
107.19 %
28.85 %
-1.49 %
(Jun 30 2025)   (Jun 30 2025)







Financial Statements
Oak Woods Acquisition's II. Quarter Investments $ 36 Millions OAKUU's Balance sheet
Oak Woods Acquisition's II. Quarter Income $ 0 Millions Quarterly OAKUU's Income Statement
OAKUU's Income by Division See OAKUU's Income by Division


OAKUU Annual Return On Investment (Sep 30 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023


Total Investments in Millions 36 44 60 0 0
Y / Y Investment Growth -18.16 % -27.06 % - - -
Net Income in Millions 0 0 9 0 0
Y / Y Net Income Growth -92.75 % -97.8 % - - -
Annual Return On Investment 0.04 % 0.43 % 14.45 % - -


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 0.04 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OAKUU's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for OAKUU's Competitors
Subscribers only: Roi for Oak Woods Acquisition's Suppliers
Subscribers only: Return On Investment for OAKUU's Customers

Other Ratios
OAKUU's Roa OAKUU's Inventory Turnover Ratio OAKUU's Growth Rates OAKUU's Dividend Statistics
OAKUU's Profitability Ratios OAKUU's Asset Turnover Ratio OAKUU's Dividend Growth
OAKUU's Roe OAKUU's Valuation Ratios OAKUU's Financial Strength Ratios OAKUU's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2025, within Healthcare Sector ROI
Capforce Inc   177.96 %
Emmis Acquisition Corp   140.55 %
Oak Woods Acquisition Corp  106.75 %
Coherus Oncology inc   105.87 %
Interpace Biosciences Inc   102.53 %
Rigel Pharmaceuticals Inc  92.61 %
Cytomx Therapeutics Inc   80.43 %
Seres Therapeutics Inc   75.04 %
Gridai Technologies Corp  75.01 %
Earth Science Tech Inc   74.07 %
Stablecoin Development Corporation  66.04 %
Novavax inc   56.96 %
Exelixis Inc   55.73 %
Biomx Inc  53.39 %
Adma Biologics Inc   49.11 %
Medinotec Inc   48.14 %
Abeona Therapeutics Inc   46.96 %
Synlogic Inc   46.41 %
Dariohealth Corp   45.05 %
Idexx Laboratories Inc  44.34 %
Entera Bio Ltd   43.13 %
Puma Biotechnology Inc   42.38 %
Agios Pharmaceuticals Inc   41.91 %
Siga Technologies Inc  38.92 %
Ptc Therapeutics inc   38.85 %
Longduoduo Co Ltd  36.87 %
Mettler toledo International Inc   36.69 %
Edwards Lifesciences Corporation  35.59 %
Minerva Neurosciences Inc   34.19 %
Arcutis Biotherapeutics Inc   34.15 %


Date modified: 2026-09-08T15:22:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.